Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinge Zhao

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Radiation Oncology (London, England)|November 11, 2019
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysisRonggui Tao, Jindong Dai, Yunjin Bai, et al.
Oncotargets and Therapy|December 28, 2018
The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysisJunru Chen, Xingming Zhang, Guangxi Sun, et al.
Nano Letters|November 14, 2024
Harnessing Cross-strand π-π Interlocking for Synergistic Enhancement of Immune Checkpoint Blocking and FerroptosisLimin Zhang, Xin Wang, Jinge Zhao, et al.
International Urology and Nephrology|March 21, 2025
Liquid-based kidney injury molecule-1 as a diagnostic and prognostic indicator in renal cell carcinoma: A systematic review and meta-analysisSike He, Dingbang Liu, Junru Chen, et al.
Analytical Chemistry|July 31, 2024
π-π Stacking Network-Based Supramolecular Peptide Nanoprobe for Visualization of the ICB-Enhanced Ferroptosis ProcessXin Wang, Jinge Zhao, Jian Zhang, et al.
Frontiers in Oncology|October 19, 2020
Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-AnalysisJunru Chen, Yuchao Ni, Guangxi Sun, et al.
International Urology and Nephrology|December 24, 2024
Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitorQian Wang, Xingming Zhang, Qiyu Zhu, et al.
European Journal of Medical Research|June 6, 2025
Drug treatment options of high-risk biochemically recurrent prostate cancer based on efficacy and safety: a systematic review and Bayesian network analysisQian Wang, Qiyu Zhu, Haoyang Liu, et al.
Scientific Reports|December 1, 2019
Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER databaseJunru Chen, Zhipeng Wang, Jinge Zhao, et al.
Cancer Management and Research|August 3, 2019
The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective studyJiandong Liu, Jinge Zhao, Mengni Zhang, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Radiation Oncology (London, England)|November 11, 2019
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysisRonggui Tao, Jindong Dai, Yunjin Bai, et al.
Oncotargets and Therapy|December 28, 2018
The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysisJunru Chen, Xingming Zhang, Guangxi Sun, et al.
Nano Letters|November 14, 2024
Harnessing Cross-strand π-π Interlocking for Synergistic Enhancement of Immune Checkpoint Blocking and FerroptosisLimin Zhang, Xin Wang, Jinge Zhao, et al.
International Urology and Nephrology|March 21, 2025
Liquid-based kidney injury molecule-1 as a diagnostic and prognostic indicator in renal cell carcinoma: A systematic review and meta-analysisSike He, Dingbang Liu, Junru Chen, et al.
Analytical Chemistry|July 31, 2024
π-π Stacking Network-Based Supramolecular Peptide Nanoprobe for Visualization of the ICB-Enhanced Ferroptosis ProcessXin Wang, Jinge Zhao, Jian Zhang, et al.
Frontiers in Oncology|October 19, 2020
Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-AnalysisJunru Chen, Yuchao Ni, Guangxi Sun, et al.
International Urology and Nephrology|December 24, 2024
Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitorQian Wang, Xingming Zhang, Qiyu Zhu, et al.
European Journal of Medical Research|June 6, 2025
Drug treatment options of high-risk biochemically recurrent prostate cancer based on efficacy and safety: a systematic review and Bayesian network analysisQian Wang, Qiyu Zhu, Haoyang Liu, et al.
Scientific Reports|December 1, 2019
Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER databaseJunru Chen, Zhipeng Wang, Jinge Zhao, et al.
Cancer Management and Research|August 3, 2019
The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective studyJiandong Liu, Jinge Zhao, Mengni Zhang, et al.
Pageof 10